Related references
Note: Only part of the references are listed.First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens
Julien Nyombayire et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice
Junghwa Lee et al.
JOURNAL OF VIROLOGY (2017)
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates
Juan Garcia-Arriaza et al.
JOURNAL OF VIROLOGY (2017)
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)
Ana Maria Henao-Restrepo et al.
LANCET (2017)
Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens
Pablo Penaloza MacMaster et al.
VACCINE (2017)
Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial
David Easterhoff et al.
PLOS PATHOGENS (2017)
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention
Lindsey R. Baden et al.
ANNALS OF INTERNAL MEDICINE (2016)
Viral vectors as vaccine platforms: from immunogenicity to impact
Katie J. Ewer et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells
Nicholas M. Provine et al.
JOURNAL OF IMMUNOLOGY (2016)
Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses
Nicholas M. Provine et al.
JOURNAL OF VIROLOGY (2016)
Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization
Pablo Penaloza-MacMaster et al.
VACCINE (2016)
Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection
Sama Adnan et al.
PLOS PATHOGENS (2016)
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
Sebastian P. Fuchs et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function
Rafael A. Larocca et al.
SCIENCE IMMUNOLOGY (2016)
Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
Lori F. Maxfield et al.
CLINICAL AND VACCINE IMMUNOLOGY (2015)
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling
Kylie M. Quinn et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection
Kevin O. Saunders et al.
JOURNAL OF VIROLOGY (2015)
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates
Juan Garcia-Arriaza et al.
JOURNAL OF VIROLOGY (2015)
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection
Timothy R. Fouts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection
Pablo Penaloza-MacMaster et al.
SCIENCE (2015)
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
Dan H. Barouch et al.
SCIENCE (2015)
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults
Caroline Ogwang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Vectored antibody gene delivery for the prevention or treatment of HIV infection
Cailin E. Deal et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Characterization of CD8+ T Cell Differentiation following SIVΔnef Vaccination by Transcription Factor Expression Profiling
James M. Billingsley et al.
PLOS PATHOGENS (2015)
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)
Jonathan D. Fuchs et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
A New Model for Catalyzing Translational Science: The Early Stage Investigator Mentored Research Scholar Program in HIV Vaccines
Blythe J. S. Adamson et al.
CTS-Clinical and Translational Science (2015)
Induction of HIV-1-Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans
Lindsey R. Baden et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Construction and Evaluation of Novel Rhesus Monkey Adenovirus Vaccine Vectors
Peter Abbink et al.
JOURNAL OF VIROLOGY (2015)
Hexon Hypervariable Region-Modified Adenovirus Type 5 (Ad5) Vectors Display Reduced Hepatotoxicity but Induce T Lymphocyte Phenotypes Similar to Ad5 Vectors
Jeffrey E. Teigler et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Longitudinal Requirement for CD4+ T Cell Help for Adenovirus Vector-Elicited CD8+ T Cell Responses
Nicholas M. Provine et al.
JOURNAL OF IMMUNOLOGY (2014)
The Canarypox Virus Vector ALVAC Induces Distinct Cytokine Responses Compared to the Vaccinia Virus-Based Vectors MVA and NYVAC in Rhesus Monkeys
Jeffrey E. Teigler et al.
JOURNAL OF VIROLOGY (2014)
Neurovirulence and Immunogenicity of Attenuated Recombinant Vesicular Stomatitis Viruses in Nonhuman Primates
David K. Clarke et al.
JOURNAL OF VIROLOGY (2014)
Augmented Replicative Capacity of the Boosting Antigen Improves the Protective Efficacy of Heterologous Prime-Boost Vaccine Regimens
Pablo Penaloza-MacMaster et al.
JOURNAL OF VIROLOGY (2014)
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
Richard D. Antrobus et al.
MOLECULAR THERAPY (2014)
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV
Mario Roederer et al.
NATURE (2014)
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
Daphne A. Stanley et al.
NATURE MEDICINE (2014)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-γ Secretion with Increased HIV-1 Infection Risk: A Cohort-Based Modeling Study
Yunda Huang et al.
PLOS ONE (2014)
Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals
Haitao Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development
George K. Lewis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
Leo Swadling et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
High-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control
Zaza M. Ndhlovu et al.
BLOOD (2013)
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
Dan H. Barouch et al.
CELL (2013)
Lessons Learned from HIV Vaccine Clinical Efficacy Trials
Tracey A. Day et al.
CURRENT HIV RESEARCH (2013)
Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization
Kylie M. Quinn et al.
JOURNAL OF IMMUNOLOGY (2013)
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)
Lindsey R. Baden et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Alternative Serotype Adenovirus Vaccine Vectors Elicit Memory T Cells with Enhanced Anamnestic Capacity Compared to Ad5 Vectors
Pablo Penaloza-MacMaster et al.
JOURNAL OF VIROLOGY (2013)
Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8+ T Cells Induced by Different Adenovirus Vectors
Wendy G. Tan et al.
JOURNAL OF VIROLOGY (2013)
The Quest for an HIV-1 Vaccine - Moving Forward
Dan H. Barouch
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Scott M. Hammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C
Jeff Alexander et al.
PLOS ONE (2013)
LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus
Danit Finkelshtein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms
Scott G. Hansen et al.
SCIENCE (2013)
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Katie J. Ewer et al.
NATURE COMMUNICATIONS (2013)
Development of replication-competent viral vectors for HIV vaccine delivery
Christopher L. Parks et al.
CURRENT OPINION IN HIV AND AIDS (2013)
Toll-like Receptor 7 Is Required for Effective Adaptive Immune Responses that Prevent Persistent Virus Infection
Kevin B. Walsh et al.
CELL HOST & MICROBE (2012)
Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
Geraldine A. O'Hara et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Gene-Based Vaccination with a Mismatched Envelope Protects against Simian Immunodeficiency Virus Infection in Nonhuman Primates
Lukas Flatz et al.
JOURNAL OF VIROLOGY (2012)
Adenovirus Serotype 26 Utilizes CD46 as a Primary Cellular Receptor and Only Transiently Activates T Lymphocytes following Vaccination of Rhesus Monkeys
Hualin Li et al.
JOURNAL OF VIROLOGY (2012)
Vaccination with Adenovirus Serotypes 35, 26, and 48 Elicits Higher Levels of Innate Cytokine Responses than Adenovirus Serotype 5 in Rhesus Monkeys
Jeffrey E. Teigler et al.
JOURNAL OF VIROLOGY (2012)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Morgane Rolland et al.
NATURE (2012)
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Dan H. Barouch et al.
NATURE (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission
Dan H. Barouch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
Stefano Colloca et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Eleanor Barnes et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses
Stephen R. Walsh et al.
VACCINE (2012)
Role of Lymphocytic Choriomeningitis Virus (LCMV) in Understanding Viral Immunology: Past, Present and Future
Xin Zhou et al.
VIRUSES-BASEL (2012)
Poxvirus Cell Entry: How Many Proteins Does it Take?
Bernard Moss
VIRUSES-BASEL (2012)
Human cytomegalovirus entry into cells
Adam L. Vanarsdall et al.
CURRENT OPINION IN VIROLOGY (2012)
ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 Challenge
Michael D. Alpert et al.
PLOS PATHOGENS (2012)
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2h study
Glenda E. Gray et al.
LANCET INFECTIOUS DISEASES (2011)
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Scott G. Hansen et al.
NATURE (2011)
Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines
Vinod Kumar Bhaskara Pillai et al.
VACCINE (2011)
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
Dan H. Barouch et al.
VACCINE (2011)
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects
Michael C. Keefer et al.
VACCINE (2011)
Canarypox and fowlpox viruses as recombinant vaccine vectors: A biological and immunological comparison
Carlo Zanotto et al.
ANTIVIRAL RESEARCH (2010)
Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
Elizabeth S. Gabitzsch et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
Dan H. Barouch et al.
NATURE MEDICINE (2010)
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
Sampa Santra et al.
NATURE MEDICINE (2010)
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity
Lukas Flatz et al.
NATURE MEDICINE (2010)
An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization
Franck Lemiale et al.
VACCINE (2010)
Heterologous HIV-based lentiviral/adenoviral vectors immunizations result enhanced HIV-specific immunity
Benyam Asefa et al.
VACCINE (2010)
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
Jinyan Liu et al.
NATURE (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
Scott G. Hansen et al.
NATURE MEDICINE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Lentiviral vectors for HIV disease prevention and treatment
Franck Lemiale et al.
VACCINE (2009)
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
Daniela Peruzzi et al.
VACCINE (2009)
Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys
Lauren E. Grandpre et al.
VACCINE (2009)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates
Surojit Sarkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Differential CD4(+) versus CD8(+) T-cell responses elicited by different poxvirus-based human immunodeficiency virus type I vaccine candidates provide comparable efficacies in primates
Petra Mooij et al.
JOURNAL OF VIROLOGY (2008)
Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys
Jinyan Liu et al.
JOURNAL OF VIROLOGY (2008)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and G gene truncation reduces neurovirulence and enhances immunogenicity in mice
David Cooper et al.
JOURNAL OF VIROLOGY (2008)
Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation
Surojit Sarkar et al.
JOURNAL OF IMMUNOLOGY (2007)
Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection
Scott N. Mueller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC
Susana Guerra et al.
JOURNAL OF VIROLOGY (2007)
Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy
Z. R. Yang et al.
CANCER GENE THERAPY (2007)
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
Peter Abbink et al.
JOURNAL OF VIROLOGY (2007)
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
Shabaana A. Khader et al.
NATURE IMMUNOLOGY (2007)
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques
Thorsten Demberg et al.
JOURNAL OF VIROLOGY (2007)
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates
J. Erik Johnson et al.
VIROLOGY (2007)
CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system
Elizabeth M. Sitati et al.
JOURNAL OF VIROLOGY (2006)
Seroprevalence of cytomegalovirus infection in the United States, 1988-1994
Stephanie A. S. Staras et al.
CLINICAL INFECTIOUS DISEASES (2006)
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
Nancy A. Wilson et al.
JOURNAL OF VIROLOGY (2006)
Transmission of lymphocytic choriomeningitis virus by organ transplantation.
Staci A. Fischer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
DM Roberts et al.
NATURE (2006)
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates:: an efficacy assessment
KM Daddario-DiCaprio et al.
LANCET (2006)
The CD8(+) T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity
TC Yang et al.
JOURNAL OF IMMUNOLOGY (2006)
Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States
E Nwanegbo et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2004)
Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein
SI Staprans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
S Kostense et al.
AIDS (2004)
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity
DH Barouch et al.
JOURNAL OF IMMUNOLOGY (2004)
Lymphocytic choriomeningitis virus infection in a province of Spain:: Analysis of sera from the general population and wild rodents
L Lledó et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-speeific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 Rhesus macaques
N Malkevitch et al.
JOURNAL OF IMMUNOLOGY (2003)
Requirement for CD4 T cell help in generating functional CD8 T cell memory
DJ Shedlock et al.
SCIENCE (2003)
Defective CD8 T cell memory following acute infection without CD4 T cell help
JC Sun et al.
SCIENCE (2003)
Lineage relationship and protective immunity of memory CD8 T cell subsets
EJ Wherry et al.
NATURE IMMUNOLOGY (2003)
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
EM Janssen et al.
NATURE (2003)
CD46 is a cellular receptor for group B adenoviruses
A Gaggar et al.
NATURE MEDICINE (2003)
Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses
PK Hocknell et al.
JOURNAL OF VIROLOGY (2002)
HIV preferentially infects HIV-specific CD4+ T cells
DC Douek et al.
NATURE (2002)
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
JW Shiver et al.
NATURE (2002)
Replication-defective vector based on a chimpanzee adenovirus
SF Farina et al.
JOURNAL OF VIROLOGY (2001)
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
NF Rose et al.
CELL (2001)
Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses
YR Seong et al.
VACCINE (2001)
Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene
T Tuboly et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Share Paper
